MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    DBS Directional programming – Institution based study of programming in PD and ET patients

    M. Moreno-Escobar, R. Elkins, S. Pallavaram, R. Tripathi (Morgantown, USA)

    Objective: To examine the use of Deep Brain Stimulation (DBS) directional programming in Parkinson Disease (PD) and Essential Tremor (ET) patients Background: DBS and its utility…
  • MDS Virtual Congress 2021

    Metadata standards to support deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease (PD)

    D. Hill, D. Stephenson, J. Brayanov, K. Claes, R. Badawy, S. Sardar, K. Fisher, S. Lee, A. Bannon, V. Terebaite, R. Bhatnagar (St Pierre Dechartreuse, France)

    Objective: A metadata framework for Digital Health Technologies (DHT) to support enhanced regulatory maturity, and to facilitate standardization and harmonization of data collection Background: DHTs…
  • MDS Virtual Congress 2021

    Effect of dopaminergic treatment on digital sensor features in Phase II PASADENA Part 1 in early Parkinson’s disease

    B. van Lier, J. Anzures Cabrera, E. Volkova-Volkmar, L. Essioux, H. Svoboda, W. Zago, G. Pagano, R. Postuma, M. Lindemann, K. Taylor, F. Lipsmeier (Basel, Switzerland)

    Objective: To characterize the sensitivity of smartphone and -watch sensor features to levodopa and dopamine agonist (DA-Tx) treatment. Background: Digital health technology tools (DHTTs) enable…
  • MDS Virtual Congress 2021

    Are physiotherapists reliable in their scoring of freezing of gait?

    A. Scully, K. Neo, E. Lim, D. Tan (Bentley, Australia)

    Objective: To determine the reliability of freezing of gait scoring through post-hoc video analysis in raters with a physiotherapy background. Background: Freezing of gait affects…
  • MDS Virtual Congress 2021

    Early-onset Dementia with Lewy Bodies and Parkinson’s Disease Dementia: A Population-based Study (2010-2015).

    E. Camerucci, C. Stang, M. Hajeb, P. Turcano, A. Mullan, D. Jones, J. Graff-Radford, O. Ross, J. Bower, B. Boeve, R. Savica (Rochester, USA)

    Objective: To examine the incidence, clinical features, and survival of early-onset Dementia with Lewy Bodies and Parkinson’s Disease Dementia (DLB/PDD) (≤55 years of age) in…
  • MDS Virtual Congress 2021

    Reproductive factors and risk of Parkinson’s disease in women: preliminary results from the French prospective cohort E3N.

    G. Pesce, F. Artaud, E. Roze, I. Degaey, A. Fournier, MC. Boutron-Ruault, A. Elbaz, M. Canonico (Villejuif, France)

    Objective: Objective: To evaluate whether reproductive factors and use of exogenous hormones are associated with the risk of Parkinson’s disease (PD) in women. Background: Background:…
  • MDS Virtual Congress 2021

    Impact of extended quarantine during the COVID-19 pandemic on Parkinson’s disease (PD) patients.

    G. Lopez, V. Kurtz, B. Charra, E. Garino, D. Ballesteros (Buenos Aires, Argentina)

    Objective: To determine the impact of extended quarantine during the COVID-19 pandemic in PD patients. Background: Due to the Covid-19 pandemic, various types of social…
  • MDS Virtual Congress 2021

    Terminal Choking in Parkinson’s Disease

    F. Herbert, A. Ling, E. Richfield, B. Wright (Gloucester, United Kingdom)

    Objective: To establish whether choking is a frequent cause of death in Parkinson’s Disease (PD), if this is a feared consequence of PD in patients/caregivers…
  • MDS Virtual Congress 2021

    Efficacy of opicapone according to different levodopa daily intakes in Parkinson’s disease patients with motor fluctuations

    G. Ebersbach, W. Poewe, J. Ferreira, D. Magalhaes, J. Rocha, P. Soares-da-Silva (Beelitz-Heilstätten, Germany)

    Objective: To evaluate the efficacy of opicapone (OPC) in Parkinson’s disease (PD) patients with motor fluctuation according to different levodopa daily intakes. Background: OPC proved…
  • MDS Virtual Congress 2021

    Randomized, Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of ABBV-0805, an Anti-Alpha-Synuclein Monoclonal Antibody in Healthy Subjects

    H. Kalluri, C. Zadikoff, L. Rueter, O. Graff, H. Xiong (North Chicago, USA)

    Objective: To evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of ABBV-0805 following administration of single ascending doses of ABBV-0805, administered as intravenous (IV) infusions…
  • « Previous Page
  • 1
  • …
  • 430
  • 431
  • 432
  • 433
  • 434
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley